Stay updated on Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Sign up to get notified when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.

Latest updates to the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision log updated: added Revision v3.3.2 and removed Revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe notice about government funding affecting site operations was removed. It formerly directed users to cc.nih.gov for operating status and opm.gov for updates.SummaryDifference0.3%

- Check34 days agoChange DetectedNo observable changes between the two screenshots; the study details, eligibility criteria, and trial design appear unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference3%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated the page version from v3.0.1 to v3.0.2; removed the Back to Top link.SummaryDifference0.2%

Stay in the know with updates to Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.